IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3568 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Article in PDF (126 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  


  In this article
    Abstract
    Introduction
    Case Report
    Discussion
    References

 Article Access Statistics
    Viewed5658    
    Printed103    
    Emailed2    
    PDF Downloaded135    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 
CASE REPORT
Year : 2004  |  Volume : 70  |  Issue : 1  |  Page : 36-38
 

Scleromyxedema with subclinical myositis


Department of Dermatology, Venereology and Leprosy, Rajah Muthiah Medical College and Hospital, Annamalai University, Annamalai Nagar

Correspondence Address:
No. 88, Auta Nagar, Sivapuri - Post, Annamalai Nagar - 608002
prasaderm@hotmail.com

   Abstract 

A 49-year-old farmer presented with papules on the face, arms, chest and back associated with sclerosis. Histopathology and PAS stain confirmed the clinical diagnosis of scleromyxedema. He also had elevated CPK levels due to myopathy. Screening for internal malignancy was negative.

How to cite this article:
Prasad P V, Joseph JM, Kaviarasan P K, Viswanathan P. Scleromyxedema with subclinical myositis . Indian J Dermatol Venereol Leprol 2004;70:36-8


How to cite this URL:
Prasad P V, Joseph JM, Kaviarasan P K, Viswanathan P. Scleromyxedema with subclinical myositis . Indian J Dermatol Venereol Leprol [serial online] 2004 [cited 2020 May 25];70:36-8. Available from: http://www.ijdvl.com/text.asp?2004/70/1/36/6817



   Introduction Top


Lichen myxedematosus is a cutaneous myxedematous state characterized by the formation of numerous lichenoid papules which coalesce together to form generalized plaques, causing extensive thickening and hardening of the skin.[1] The disease usually affects adults between 30 and 50 years of age. Cardiovascular abnormalities can occur in 10% of cases. Others may complain of extreme muscular weakness and lassitude due to myopathic or neurological involvement.[2] Paraproteinemia is commonly found in spite of normal serum proteins. There is an elevation of IgG k light chain with mobility moving to the cathode.[3] Histopathology of the skin lesion reveals large amounts of mucin. The mucinous infiltrate is pronounced in the upper dermis and is associated with an increase in fibroblasts and collagen. The collagen bundles in the upper dermis are arranged irregularly.[4] There is a wide range of treatment alternatives that are only partially acceptable because of lack of therapeutic efficacy or because of severe complications. They are prednisone, cyclophosphamide, melphalan, isotretinoin, intravenous immunoglobulins, thalidomide, homologous bone marrow transplant and extracorporeal photochemotherapy.[2]


   Case Report Top

A 49-year-old male farmer complained of hyperpigmented skin lesions of 3 years' duration and puffiness of face of one month's duration. He initially noticed darkening of the skin on the face which progressively involved the upper chest, upper back and upper arms. Pruritus was moderate. At the same time, the patient also noticed a papular eruption on these sites. One month prior to his visit to the hospital, he noticed puffiness of the face. There was no history of atopy, extra-marital sexual exposure, photosensitivity or systemic complaints.

On examination there was no pallor, cyanosis, clubbing or pedal edema. The axillary lymph nodes were palpable bilaterally, and were firm and nontender. The pulse rate, blood pressure, systemic examination, genitalia and per rectal examination were all within normal limits.

Cutaneous examination revealed multiple infiltrated plaques over the face, neck anterior chest wall, interscapular region, back and upper limbs [Figure - 1], [Figure - 2], [Figure - 3]. There was puffiness of the face and inability to retract the lower eyelids. The skin was bound down at these sites. There were also hyperpigmented papules over the face, neck, scalp and back. The forehead creases were spared. The scalp showed diffuse alopecia. The palms, soles, nails and mucosa were normal.

A clinical diagnosis of scleromyxedema was made and the patient was further investigated. The hemoglobin was 8 g%, the ESR was normal, the total and differential white blood count were normal, and the platelet count was 1,00,000 cells/cmm. The peripheral smear revealed a normocytic normochromic anemia. The urine was normal and there was no occult blood in the stool. The blood sugar, and renal function tests and thyroid function tests were normal, but the liver function tests revealed increased aspartate aminotransferase (70 U/L) and alanine aminotransferase (80 U/L) levels. The serum alkaline phosphatase was 149 U/L and the serum creatinine phosphokinase (CPK) was 247 U/L. The twenty four hours urinary protein estimation and ultrasonography of the abdomen were normal. A chest X-ray and electrocardiogram were within normal limits. ELISA for HIV screening was negative. The serum electrophoretic pattern revealed a relative increase in gamma globulin, i.e. 1.3 U/L (normal 0.5 - 1 U/L). Electromyography (EMG) from the right deltoid muscle showed prolonged insertional activity, few fibrillation potentials and incomplete interference pattern with short duration, low amplitude polyphasic units. All these features were suggestive of myositis. A skin biopsy revealed mucin deposition in the upper dermis which was confirmed by an Alcian Blue stain [Figure - 4]. The findings of a biopsy from the right deltoid muscle were consistent with myopathy.

The patient was started on combination therapy with cyclophosphamide 50 mg twice a day and oral prednisolone 40 mg per day. Prednisolone was tapered to 20 mg after one month. With this combination therapy the patient subjectively improved and the papules improved by 75% after one month. Both the drugs are being continued and the patient is being regularly followed-up.


   Discussion Top


Our patient was diagnosed to have scleromyxedema on the basis of chronicity of skin lesions, a generalized papular and sclerodermoid eruption, and mucin deposition, fibroblast proliferation and fibrosis on histopathology with normal thyroid function tests. Extensive screening did not reveal any internal malignancy. The serum creatinine phosphokinase was raised and this was confirmed by serial estimations. Electromyography and muscle biopsy revealed myopathy but there was no clinical evidence of myositis.

Scleromyxedema may be associated with various underlying conditions like neurological events, scleroderma, atherosclerosis, dermatomyositis, multiple keratoacanthomas and an underlying carcinoma.[5] Launay described a 41-year-old man with scleromyxedema and dermatomyositis.[6] Slight to severe proximal muscle weakness is found in 27% of patients and occasionally associated with slight elevation of muscle enzymes and inflammatory electromyographic findings. Thus our patient had an interesting association of increased muscle enzymes and myopathy with scleromyxedema in the absence of clinical evidence of myositis.

Our patient had increased gamma globulin levels but we could not investigate this further to learn if it was a monoclonal spike and moved toward cathode which could have supported our diagnosis. 

   References Top

1.Gottron HA. Scleromyxedema. Arch Dermatol Syphilol 1954;199:545-7.  Back to cited text no. 1    
2.Black MM, Gawkrodger DJ, Seymour CA, Weismann K. Mucinosis. Metabolic and nutritional disorders. In: Champion RH, Burton JH, Burns DA, et al, editors. Textbook of dermatology. 6th ed. Oxford: Blackwell Science; 1998. p. 2616-18.  Back to cited text no. 2    
3.Ayala F, Balato N, Ceparano S, Castello G. Immunochemical characterization of the abnormal paraprotein in a case of scleromyxedema. Clin Exp Dermatol 1984;9:351-7.  Back to cited text no. 3  [PUBMED]  
4.Maize J, Metcalf J. Metabolic diseases of the skin. In: Elder D, Elenitsas R, Jaworsky C, et al, editors. Lever's Histopathology of the skin. 8th ed. Philadelphia: Lippincott-Raven; 1997. p. 389.  Back to cited text no. 4    
5.Dirneen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1995;33:37-43.  Back to cited text no. 5    
6.Launay D, Hatron PY, Delaporte E, Hachulla E, Devulder B, Piette F. Scleromyxedema (lichen myxedematous) associated with dermatomyositis. Br J Dermatol 2001;144:359-62.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]

 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow